Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.
about
Amiodarone versus other pharmacological interventions for prevention of sudden cardiac deathAmiodarone versus other pharmacological interventions for prevention of sudden cardiac deathUse of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrestImplantable cardioverter defibrillators work--so why aren't we using them?Debate: Do all patients with heart failure require implantable defibrillators to prevent sudden death?Debate: Do all patients with heart failure require implantable defibrillators to prevent sudden death?Should all patients receive dual chamber pacing ICDs? The rationale for the DAVID trialICD discrimination of SVT versus VT with 1:1 V-A conduction: A review of the literatureQuality of Life in Patients with an Implantable Cardioverter Defibrillator: A Systematic ReviewEuropean Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm SocietyImplantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerationsOptimal antiarrhythmic drug therapy for electrical stormA Questionable Indication For ICD Extraction After Successful VT Ablation2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theTreatment of the elderly post-myocardial infarction patientPreventing sudden death and the use of prophylactic implanted defibrillatorsProphylactic implantable cardioverter defibrillator in heart failure: the growing evidence for all or Primum non nocere for some?Effect of Sleep-Disordered Breathing on Appropriate Implantable Cardioverter-Defibrillator Therapy in Patients With Heart Failure: A Systematic Review and Meta-Analysis.Psychological indices and phantom shocks in patients with ICD.Towards a better risk stratification for sudden cardiac death in patients with structural heart disease.Real-world data on the lifespan of implantable cardioverter-defibrillators depending on manufacturers and the amount of ventricular pacing.Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE-registry.Cost-effectiveness of primary prevention implantable cardioverter defibrillator treatment: data from a large clinical registry.Nonthoracotomy implantable defibrillator lead extraction: results and comparison with extraction of pacemaker leads.Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study.Incremental net benefit in randomized clinical trials with quality-adjusted survival.Patients with an ICD can safely resume work in industrial facilities following simple screening for electromagnetic interference.Distinct clinical features in the recipients of the implantable cardioverter defibrillator in Taiwan: a multicenter registry study.Syncope in the patient with nonischemic dilated cardiomyopathy.Prediction and prevention of sudden cardiac death in heart failure.Impact of the multicenter automatic defibrillator implantation trial on clinical practice.Implantable cardiac arrhythmia devices--Part II: implantable cardioverter defibrillators and implantable loop recorders.Impact of the main implantable cardioverter-defibrillator trials for primary and secondary prevention in Italy: a survey of the national activity during the years 2001-2004.Implantable cardioverter defibrillator: charge saver, not syncope saver!Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%.Economic evaluations of implantable cardioverter defibrillators: a systematic review.Regression methods for cost-effectiveness analysis with censored data.A review of the management of patients after percutaneous coronary intervention.Use of implantable cardioverter-defibrillator in inherited arrhythmogenic diseases: data from Italian ICD Registry for the years 2001-6.Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction
P2860
Q24187185-A3F05299-ECD3-40D2-A2A1-7348B1DF1CF5Q24240892-F762C0A9-D3B1-4610-AEBB-291884DECDC8Q24685115-EF4AC0F9-A9EB-4E24-AAD3-23AF1F043314Q24685141-1C6FB4F5-2C27-46A4-8960-DE1D48F648EFQ24792641-253F2C4A-EE3E-474B-9E41-AE3173238DDEQ24792670-A31B51B1-59B7-43EF-8EB5-F03C6F72DCF3Q24806880-597F6955-1279-4943-A190-2021D8E8637CQ26748689-B2CA53CA-0BBD-4900-87D2-F3706AA5D678Q26776104-15C91A84-DF29-49B4-BC44-49449E7CA2FDQ26796261-8D7F6995-6B88-4EC9-A942-38361592A79DQ26852920-630AE7BC-A6F0-42BD-9BE5-2D12DCFCE4BBQ27027096-E40749F4-184A-4161-943B-01E1D0D1C001Q28082167-9B53588A-2DE1-4744-BE30-D98A815BE1E0Q28087002-1B8A2E99-8F04-4395-89C7-31FD1A74A16BQ28191018-4B72D87F-2D11-4F49-A5F9-1706150DB617Q28200390-92651495-4208-4279-B942-A44B953F2154Q30235600-D055CDDA-4633-4073-BDD4-D73EC05E587BQ30274736-A6C94AC9-F3E9-445D-83DA-6DFAF0180F06Q30441783-3B3C3EA6-3D74-411D-B211-1EAF69495D28Q30490546-A7226BDA-00B7-4D3C-90E0-A8B66C16B001Q30558560-11CCF3D4-A937-4098-BED8-6EAAB88D765FQ30609810-CF1167F3-E4CB-4C51-8C1C-147A2244CD42Q30664657-0B6DB19E-26DB-4005-9EE0-C4080BFB1478Q30821143-B3086576-0B55-4FCB-9DA0-5FF1B247735CQ31007688-9C500E4E-298C-4249-9D22-28179C0A934FQ33148478-BF4204C7-284F-4FE0-A291-EB6C9965999CQ33149187-7A7F07BF-11BE-4A6B-95D6-A9D8FFD2290AQ33150718-0597DE37-A9F5-481E-8372-264C3CCC9D78Q33150877-79EA7CF0-CFCE-472D-8E23-591DBC364123Q33152534-2FBBB968-0696-46EB-8298-811EA35C5F39Q33153560-72A44E18-4518-42E1-AEB7-C281711220D7Q33153984-DD879990-696C-4619-8BB8-977BA207256DQ33154567-554A8B34-B56F-4BF8-B5C3-EE3E80F2DED0Q33159447-38070BD9-5761-4FE2-95F8-7C6642272D14Q33163845-97164420-DD25-4E49-B6D7-BC574D2702B2Q33164873-CF810BDD-3B25-4769-B3A2-434C800748C8Q33208500-9C1C6B50-00C5-4BF3-9DD8-632CE75835B5Q33371206-B5C8EC08-F4E4-452E-A23F-2DE8C0B77404Q33424947-4C7E8D13-BD14-4D46-9A96-474778813882Q33552944-9F390C0E-3554-4ADB-880F-5F02BA9DBFFE
P2860
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Canadian implantable defibrill ...... ibrillator against amiodarone.
@ast
Canadian implantable defibrill ...... ibrillator against amiodarone.
@en
type
label
Canadian implantable defibrill ...... ibrillator against amiodarone.
@ast
Canadian implantable defibrill ...... ibrillator against amiodarone.
@en
prefLabel
Canadian implantable defibrill ...... ibrillator against amiodarone.
@ast
Canadian implantable defibrill ...... ibrillator against amiodarone.
@en
P2093
P1433
P1476
Canadian implantable defibrill ...... ibrillator against amiodarone.
@en
P2093
Connolly SJ
Mitchell LB
Roberts RS
P304
P356
10.1161/01.CIR.101.11.1297
P407
P577
2000-03-01T00:00:00Z